Fibrin induction of tissue factor expression in human vascular endothelial cells

Circulation

Volumn 96, Issue 2, 1997, Pages 605-613

  Contrino, Josephine ^a   Goralnick, Sandra ^a   Qi, Jiafan ^a   Hair, Gregory ^b,c   Rickles, Frederick R ^a,b,c   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Coagulation; Endothelium; Endothelium derived factors; Fibrin; Tissue factor

Indexed keywords

FIBRIN; THROMBOPLASTIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRIN CLOT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; HUMANS; RNA, MESSENGER; THROMBOPLASTIN;

EID: 0030762544     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Colvin RB, Johnson RA, Mihm MC, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity. J Exp Med. 1973;138: 686-698.
2. Accini L, Dixon FJ. Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. Am J Pathol. 1979;96: 477-491.
3. Rickles FR, Edwards RL. Leukocytes and tumor cells in thrombosis. In: Colman RW, Hursh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, Pa: JB Lippincott Co; 1994:1164-1179.
4. Dvorak HF. Abnormalities of hemostasis in malignant disease. In: Colman RW, Hursh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, Pa: JB Lippincott Co; 1994:1238-1254.
5. Malik AB, van der Zee H. Mechanisms of pulmonary edema induced by microembolization in dogs. Circ Res. 1978;42:73-79.
6. Malik AB, Johnson A, Tahamont MV. Mechanisms of lung vascular injury after intravascular coagulation. Ann N Y Acad Sci. 1982;384:213-234.
7. Wood RM, Bick MW. The effect of heparin on the ocular tuberculin reaction. Arch Ophthalmol. 1959;61:709-711.
8. Cohen SB, Benacerraf B, McCluskey RT, Ovary Z. Effects of anticoagulants on delayed hypersensitivity reaction. J Immunol. 1967;98: 351-358.
9. Colvin RB, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity, II: kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975;14:377-381.
10. Edwards RL, Rickles FR. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science. 1978;200:541-543.
11. Colvin RB, Mosesson MW, Dvorak HF. Delayed type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest. 1979;63:1302-1306.
12. 1-42 is a multidomained neutrophil chemoattractant. Blood. 1988;71:1470-1475.
13. Senior RM, William WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. J Clin Invest. 1986; 77:1014-1019.
14. Ming GE, Tang G, Rayan T, Malik A. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest. 1992;90:2508-2510.
15. Languino L, Plescia J, Duperray A, Brian A, Plow E, Geltosky J, Alterieri D. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell. 1993;73: 1423-1434.
16. Ramsby ML, Kreutzer DL. Fibrin induction of thrombospondin in corneal endothelial cells in vitro. Invest Ophthalmol Vis Sci. 1993; 34:165-174.
17. Ramsby ML, Kreutzer DL, Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro. Invest Ophthalmol Vis Sci. 1993;34:3207-3219.
18. Erban J, Wagner DD. A 130 kDa protein on endothelial cells binds to amino acid 15-42 of BB chain of fibrinogen. J Biol Chem. 1992;267: 2451-2458.
19. Rebes J, Francis C, Wagner D. Fibrin-induced release of vWF from endothelial cells. J Clin Invest. 1987;79:117-123.
20. Weimar B, Delvos B. The mechanism of fibrin induced disorganization of cultured human endothelial cell monolayers. Arteriosclerosis. 1985;6:136-145.
21. Rickles FR, Levin J, Hardin JA, Barr CF, Conrad ME. Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response. J Lab Clin Med. 1977;89:792-803.
22. Dinarello CA. An update on human IL1 from molecular biology to clinical relevance. J Clin Immunol. 1985;5:287-297.
23. Libby P, Ordovas J, Auger K, Robbins A, Birinyl L, Dinarella C. Endotoxin and TNF induce IL-1 gene expression in adult vascular endothelial cells. Am J Pathol. 1986;124:179-185.
24. Rogers GM. Hemostatic properties of normal and perturbed vascular cells. FASEB J. 1988;2:166-123.
25. Jones TR, Kao KJ, Pizzo SV, Bigner DD. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Am J Pathol. 1981;103:304-308.
26. Horat R, Palade GE. Thrombomodulin and thrombin localization on the vascular endothelium. Eur J Cell Biol. 1993;61:299-313.
27. 2-Macroglobulin on human vascular endothelium. J Exp Med. 1976;14:1.
28. Goldsmith GH Jr, Ziats NP, Robertson AL Jr. Studies on plasminogen activator and other proteases in subcultured human vascular cells. Exp Mol Pathol. 1981;35:257-264.
29. Levin EG, Loskutoff DJ. Comparative studies of the fibrinolytic activity of cultured vascular cells. Thromb Res. 1979;15:869-878.
30. Bevilacqua MP, Gimbrone MH. Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost. 1987;13: 425-433.
31. Qi J, Kreutzer DL. Fibrin activation of vascular endothelial cell induction of IL-8 expression. J Immunol. 1995;155:867-876.
32. Ribaudo RK. Fibrin and Pulmonary Inflammation. Storrs, Conn: University of Connecticut; 1987. PhD dissertation.
33. McEver R, Becktead J, Moore K, Marshall CL, Bainton D. GMP-140, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99.
34. Towbin H, Theophil S, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
35. Contrino J, Hair GA, Schmeizl MA, Rickles FR. Kreutzer DL. In situ characterization of antigenic and functional tissue factor expression in human tumors using monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol. 1994;145:1315-1322.
36. Hair GA, Padula S, Zeff RA, Schmeizl M, Contrino J, Kreutzer DL, de Moreloose P, Boyd AW, Stanley I, Burgess AW, Rickles FR. Tissue factor expression in human leukemic cells. Leuk Res. 1996; 20:1-11.
37. Korn JH, Rickles FR, Edwards RL, Ewan VA, Myers TJ, Onder O. Mononuclear cell modulation of fibroblast procoagulant activity. J Lab Clin Med. 1982;99:657-668.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;163:156-159.
39. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991; 66:67-79.
40. Rivers RPA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. J Haematol. 1975;30:311.
41. Rickles FR, Bobrove AM. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood. 1979;54:359-370.
42. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986;163:740-745.
43. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol. 1989;134: 1087-1097.
44. Drake TA, Cheng J, Chang AI, Taylor FB Jr. Expression of tissue factor, thrombomodulin and E selectin in baboons with lethal E. coli sepsis. Am J Pathol. 1993;142:1458-1470.
45. Faulk WP, Labarrere CA, Carson SD. Tissue factor: identification and characterization of cell types in human placentae. Blood. 1990; 76:86-96.
46. Contrino J, Hair GA, Kreutzer DL, Rickles FR. In situ expression of antigenic and functional tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2:209-245.
47. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kB binding sites. J Exp Med. 1991;174:1517-1526.
48. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 1994;8:385-390.
49. Mackman N. Regulation of the tissue factor gene. FASEB J. 1995;9: 883-889.
50. Rickles FR, Hair GA, Zeff RA, Lee E, Bona RD. Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost. 1995;74:391-395.
51. Donovan-Peluso M, George LD, Hasset AC. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells. J Biol Chem. 1994;269:1361-1369.
52. Bloem LJ, Chen L, Konigsberg WH, Bach R. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol. 1989;139:418-423.
53. Gregory SA, Morrissey JH, Edgington B. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9:2752-2755.
54. Schwartz BS, Bradshaw JD. Differential regulation of tissue factor and plasminogen activator inhibitor in human mononuclear cells. Blood. 1989;74:1644-1650.
55. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem. 1989;264:20705-20718.
56. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990;265: 9782-9787.
57. Bartha K, Brisson C, Archipoff G, de la Salle C, Lanza F, Cazenave JP, Beretz A. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem. 1993;268:421-429.
58. Marguerie G, Plow E, Edgington T. Human platelets pose an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979;254:5357-5363.
59. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci U S A. 1987;84:6471-6475.
60. Conforti G, Zanetti A, Colella S, Abbadini M, Marchisio P, Pytela R, Gioancotti F, Tarone G, Languino L, Dejana E. Interaction of fibrinonectin with cultured human endothelial cells: characterization of the specific receptor. Blood. 1989;73:1576-1585.
61. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood. 1995;86:1802-1810.